Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Hepatic manifestations and impact of COVID-19 on the cirrhotic patient
2020
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial
2008
Acute kidney injury
2012 Standout
Cancer burden in the year 2000. The global picture
2001 Standout
The effect of 1 month of therapy with midodrine, octreotide‐LAR and albumin in refractory ascites: a pilot study
2009
Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: Potential new therapies and vaccines
1994
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus
2002
Pathogenesis of Hepatorenal Syndrome: Implications for Therapy
2015
Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis
2016
Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China
1999
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
2012
Intensive Care Unit Management of Patients with Liver Failure
2014
Antibody-Based Detection Tests for the Diagnosis of Helicobacter pylori Infection in Children: A Meta-Analysis
2008
Adrenocortical dysfunction in liver disease: A systematic review
2012
Renal Failure in Cirrhosis
2009
Update on adrenal insufficiency in patients with liver cirrhosis
2013
Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
1998
Esophageal Cancer
2003 Standout
Acute Kidney Injury: New Concepts
2008
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta‐analysis of randomized controlled trials
2010
Terlipressin for hepatorenal syndrome
2012
Acute kidney injury
2019 Standout
Acute kidney injury
2021 Standout
Symptomatic Benefit from EradicatingHelicobacter pyloriInfection in Patients with Nonulcer Dyspepsia
1998
Hepatorenal Disorders
2015
Systematic Review of Randomized Trials on Vasoconstrictor Drugs for Hepatorenal Syndrome
2009
Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome
2018
Acute kidney injury in cirrhosis
2008
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial
2015
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Comparison of Total Cortisol, Free Cortisol, and Surrogate Markers of Free Cortisol in Diagnosis of Adrenal Insufficiency in Patients With Stable Cirrhosis
2013
Albumin infusion in patients undergoing large-volume paracentesis: A meta-analysis of randomized trials
2011
Helicobacter pyloriInfection
2002 Standout
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice
2012
Prospects for the Development of a Vaccine Against Helicobacter pylori
1996
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
2004 Standout
An Open Label, Pilot, Randomized Controlled Trial of NoradrenalineVersusTerlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response
2008
Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio
2005
Predictors of Response to Therapy With Terlipressin and Albumin in Patients With Cirrhosis and Type 1 Hepatorenal Syndrome
2009
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
A Review of Coronavirus Disease-2019 (COVID-19)
2020 Standout
Translocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
2000 StandoutScience
Serologic detection of infection with cagA+ Helicobacter pylori strains
1995
Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes
2015
cag , a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors
1996 Standout
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
Terlipressin in Hepatorenal Syndrome
2011
Helicobacter pylori and stomach cancer: a case-control study in Venezuela.
2000
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin
1995
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Terlipressin versus other vasoactive drugs for hepatorenal syndrome
2017
Helicobacter pylori Adhesin Binding Fucosylated Histo-Blood Group Antigens Revealed by Retagging
1998 StandoutScience
Acute kidney injury in cirrhosis: implications for liver transplantation
2019
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
Seroprevalence of cytotoxin‐associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in South China
1999
Epidemiology of gastric cancer
2006 Standout
Structure of cag pathogenicity island in Japanese Helicobacter pyloriisolates
1999
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long‐term mortality
2014
Works of Anna Morgando being referenced
Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) ofHelicobacter pylori
1993
Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: Experience from a nosocomial cluster of infection
2012
Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: Standard vs half albumin doses. A prospective, randomized, unblinded pilot study
2011
Chronic infection in woodchucks infected by a cloned hepatitis delta virus
1993
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
2007
OC-30 Adrenal dysfunction in nonseptic cirrhotic patients with ascites: Impact on survival
2011
203 Noradrenaline vs terlipressin in hepatorenal syndrome: A prospective, randomized study
2006
How accurate is the culture of Helicobacter pylori in a clinical setting? An appraisal.
2005